Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer

SIMPLE SUMMARY: In clinically localized prostate cancer, risk stratification (low-, intermediate- and high-risk) is crucial for the management of such a heterogenic disease, and it is based only on clinicopathologic features (i.e., baseline prostate-specific antigen (PSA), Gleason score and clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingrosso, Gianluca, Alì, Emanuele, Marani, Simona, Saldi, Simonetta, Bellavita, Rita, Aristei, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781984/
https://www.ncbi.nlm.nih.gov/pubmed/35055380
http://dx.doi.org/10.3390/jpm12010065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781984/
https://www.ncbi.nlm.nih.gov/pubmed/35055380
http://dx.doi.org/10.3390/jpm12010065

Ejemplares similares